
Tuesday, March 09, 2004 10:15:21 AM
TORONTO, ONTARIO--Avrom E. Howard, President and CEO of Odyssey
Resources Limited (ODX:TSXV) reports that the Company has
received additional results from its ongoing 10,000 meter
trenching program at the Tavsan Gold property in western Turkey.
Tavsan hosts an historic gold resource (that Company management
views as reliable but will continue to refer to as an Inferred
Resource until independently confirmed in accordance with the
provisions of National Instrument 43-101) of 280,000 ounces (0.5
gram per tonne cutoff, specific gravity of 2.5) within a surface
area of roughly 325 by 400 meters. The current trenching program,
based to a large extent upon the known distribution of gold on
surface from historic sampling, is aimed at extending this zone
by up to 1,000 meters in length and from 100 to 500 meters in
width.
Current results cover portions of trenches A, B and C, and extend
the strike length of the main known zone of mineralization (the
"Main Zone") by at least 400 meters. Additionally, the trenches
span a vertical range of more than 60 meters, thus extending
mineralization vertically below the depth tested by previous
drilling. Company management views the combination of an
expanding surface area and greater vertical extent of
mineralization as offering excellent potential for significantly
increasing the gold resource at Tavsan.
The chart below summarizes highlights from trenches A, B and C,
and restates those from trenches D and E. A complete log of all
sample intervals for which results have been obtained, to date,
will be posted on the Company's website and updated as additional
results are received.
----------------------------------------
Trench Interval Length Gold
(meters) (meters) (grams per
tonne)
----------------------------------------
A 235-245 10 1.54
----------------------------------------
285-295 10 0.48
----------------------------------------
B 35-40 5 3.03
----------------------------------------
182-188 6 0.96
----------------------------------------
278-288 10 0.99
----------------------------------------
310-317 7 0.92
----------------------------------------
416-465 49 0.82
----------------------------------------
C 210-322 112 0.66
----------------------------------------
497-573 76 0.31
----------------------------------------
D 220-224 4 6.94
----------------------------------------
239-523 284 0.96
----------------------------------------
535-573 38 2.85
----------------------------------------
587-593 6 3.85
----------------------------------------
E 372-626 254 0.88
----------------------------------------
635-673 38 1.11
----------------------------------------
.....................
Tavsan hosts oxidized, leachable, sediment-hosted epithermal gold
in silicified rocks found within a widespread zone of
disseminated and structurally controlled mineralization exposed
at surface. Results from trenches F, G and H, up to 600 meters
along strike from the main zone of mineralization, are pending.
Historic sampling has already defined gold mineralization at
surface over a large part of this area. Sampling of these
trenches is currently underway, and results will be reported as
they become available.
A 2,000-meter, wide diameter core diamond drilling program is
planned, has recently been permitted, and is scheduled to begin.
This program is intended to confirm the historic gold resource,
then extend it in all directions and at depth.
A quality control program consisting of randomly inserted
duplicate and standard check samples will continue to ensure
accurate and reliable results in this program. Samples are being
analyzed by ISO9002 certified ALS Chemex in Vancouver, Canada,
with sample preparation completed by ALS's laboratory in Turkey.
Odyssey President and CEO, Avrom E. Howard, MSc, FGA, PGeo is the
Company's Qualified Person responsible for the preparation of
this news release and for the supervision of, and reporting on
this project.
The statements made in this Press Release may contain
forward-looking statements that may involve a number of risks and
uncertainties. Actual events or results could differ materially
from the Company's expectations and projections. The TSX Venture
Exchange has neither approved nor disapproved the information
contained in this press release.
-30-
FOR FURTHER INFORMATION PLEASE CONTACT:
John Buckle,
Vice President for Marketing and Investor Relations
416-362-6955
jebuckle@odysseyresources.com
www.odysseyresources.com
Ed

Liked By
Spread the love. Be the first to like this post!
Recent ODX News
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 01/27/2023 03:03:00 PM
- Omega Diagnostics Group PLC Director/PDMR Shareholding • UK Regulatory (RNS & others) • 01/27/2023 09:36:00 AM
- Triad hails recovery; Alpha Group profit tops outlook • Alliance News • 01/18/2023 02:54:52 PM
- Team17 to beat expectations; IOG "disappointed" • Alliance News • 01/18/2023 11:09:54 AM
- Omega Diagnostics Group PLC Trading update • UK Regulatory (RNS & others) • 01/18/2023 07:00:00 AM
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 01/16/2023 10:56:00 AM
- Omega Diagnostics has big US opportunity for FoodPrint • Alliance News • 01/06/2023 09:28:47 PM
- Omega Diagnostics receives first FoodPrint order from CLIA lab in US • Alliance News • 01/06/2023 09:42:06 AM
- Omega Diagnostics Group PLC US expansion update • UK Regulatory (RNS & others) • 01/06/2023 07:00:00 AM
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 01/03/2023 12:34:00 PM
- Omega Diagnostics Group PLC Second Price Monitoring Extn • UK Regulatory (RNS & others) • 12/13/2022 04:40:00 PM
- Omega Diagnostics Group PLC Price Monitoring Extension • UK Regulatory (RNS & others) • 12/13/2022 04:35:00 PM
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 12/13/2022 12:01:00 PM
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 11/30/2022 09:35:00 AM
- Omega Diagnostics receives CD4 deferred consideration • Alliance News • 11/25/2022 11:37:36 AM
- Omega Diagnostics Group PLC Receipt of deferred consideration • UK Regulatory (RNS & others) • 11/25/2022 07:00:00 AM
- Omega Diagnostics turns to interim loss but bets on US market • Alliance News • 11/24/2022 11:57:27 AM
- Omega Diagnostics Group PLC Half-year Report • UK Regulatory (RNS & others) • 11/24/2022 07:00:00 AM
- Omega Diagnostics Group PLC Second Price Monitoring Extn • UK Regulatory (RNS & others) • 11/23/2022 04:41:00 PM
- Omega Diagnostics Group PLC Price Monitoring Extension • UK Regulatory (RNS & others) • 11/23/2022 04:36:00 PM
- Omega Diagnostics Group PLC Second Price Monitoring Extn • UK Regulatory (RNS & others) • 11/23/2022 02:05:00 PM
- Omega Diagnostics Group PLC Price Monitoring Extension • UK Regulatory (RNS & others) • 11/23/2022 02:00:00 PM
- Omega Diagnostics Group PLC Holding(s) in Company • UK Regulatory (RNS & others) • 11/18/2022 12:09:00 PM
- Omega Diagnostics Group PLC Second Price Monitoring Extn • UK Regulatory (RNS & others) • 11/16/2022 02:06:00 PM
- Omega Diagnostics Group PLC Price Monitoring Extension • UK Regulatory (RNS & others) • 11/16/2022 02:00:00 PM
1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • CBDW • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM